http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fc078c6bf65a9740b291c2df667f7da
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Rohr |
| name | Ulrich-Peter Rohr |
| given-name | Ulrich-Peter |
| organization-name | 7Swiss Agency for Therapeutic Products (Swissmedic), Switzerland. From the Department of Hematology, Oncology and Clinical Immunology, University of Düsseldorf; German Resource Center for Genome Research, Berlin; German Cancer Research Center, Heidelberg; and Department of Chemical Oncology, University of Düsseldorf, Germany. 4Swiss Agency for Therapeutic Products (Swissmedic), Bern, Switzerland. From the Duke University Medical Center, Durham, NC; Memorial Sloan-Kettering Cancer Center, New York, NY; University Hospital Gasthuisberg, Leuven, Belgium; Cancer ResearchUK, Glasgow, United Kingdom; F. Hoffmann-La Roche, Basel, Switzerland; and Albert-Ludwigs-Universität Freiburg, Freiburg, Germany. From the Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Duesseldorf, Germany; Harvard Institutes of Medicine, Boston, MA; the Department of Neurophysiology, Heinrich Heine University, Duesseldorf, Germany; the Department of Endocrinology, Heinrich Heine University, Duesseldorf, Germany; and the German Resource Center for Genome Research, Berlin/Heidelberg, Germany. 1Klinik für Hämatologie, Onkologie und klinische Immunologie and 10F. Hoffmann-La Roche AG, Basel, Switzerland. Hematology, Oncology, and Clinical Immunology, Heinrich Heine University, D-40255 Düsseldorf, Germany; Division Clinical Assessment, Authorisation Sector, Swissmedic Swiss Agency for Therapeutic Products, Bern, Switzerland Authors' Affiliations: 1Institut Gustave Roussy, Villejuif, France; 2F. Hoffmann-La Roche, Basel, Switzerland; and 3Genentech, Inc., San Francisco, California 1Klinik für Hämatologie, Onkologie und klinische Immunologie, |
Incoming Links
Total number of triples: 38.